120 related articles for article (PubMed ID: 37883753)
1. Efficacy and Safety of Drug-Coated Balloon in Elderly Patients with Intrastent Restenosis After Lower Extremity Arteriosclerotic Obliterans After Rotarex Thrombus Removal.
Liu D; Liu W
Altern Ther Health Med; 2024 Feb; 30(2):124-132. PubMed ID: 37883753
[TBL] [Abstract][Full Text] [Related]
2. Midterm Results of Drug-Coated Balloon Alone or Combined with Rotarex Thrombectomy Device for Treatment of Subacute Femoropopliteal Artery Thrombotic Occlusion.
Fan W; Lu S; Tan J; Cui X; Liang K; Zhu L; He Q; Yu B; Shi W
Ann Vasc Surg; 2023 May; 92():240-248. PubMed ID: 36503024
[TBL] [Abstract][Full Text] [Related]
3. [To investigate the role of the AAC-8 scoring in predicting restenosis or occlusion of lower extremity arteries after dilatation and angioplasty with DCB].
Cai J; Zhang ZX; Qiao T; Li XQ; Wang W
Zhonghua Yi Xue Za Zhi; 2024 Jan; 104(5):332-336. PubMed ID: 38281800
[No Abstract] [Full Text] [Related]
4. Excimer laser ablation combined with drug-coated balloon versus drug-coated balloon in the treatment of de novo atherosclerotic lesions in lower extremities (ELABORATE): study protocol for a real-world clinical trial.
Jiang X; Fan L; Chen B; Jiang J; Liu J; Qiao G; Ju S; Shi Y; Ma T; Lin C; Fang G; Guo D; Xu X; Dong Z; Fu W
BMC Cardiovasc Disord; 2022 Jul; 22(1):317. PubMed ID: 35842583
[TBL] [Abstract][Full Text] [Related]
5. Drug-Coated Balloon Angioplasty for Femoropopliteal In-Stent Restenosis.
Cassese S; Wolf F; Ingwersen M; Kinstner CM; Fusaro M; Ndrepepa G; Ibrahim T; Ott I; Lammer J; Krankenberg H; Fusaro M
Circ Cardiovasc Interv; 2018 Dec; 11(12):e007055. PubMed ID: 30562083
[TBL] [Abstract][Full Text] [Related]
6. Drug-Coated Balloon Angioplasty Versus Standard Uncoated Balloon Angioplasty for Long Femoropopliteal Lesions: Post Hoc Analysis of the 24-Month Results of the AcoArt I Study.
Jia S; Liu J; Sun G; Zhang J; Zhuang B; Jia X; Fu W; Wu D; Wang F; Zhao Y; Guo P; Bi W; Wang S; Guo W;
Ann Vasc Surg; 2022 May; 82():70-80. PubMed ID: 34902474
[TBL] [Abstract][Full Text] [Related]
7. Paclitaxel-Coated Balloon vs Uncoated Balloon Angioplasty for Treatment of In-Stent Restenosis in the Superficial Femoral and Popliteal Arteries: The COPA CABANA Trial.
Tepe G; Schroeder H; Albrecht T; Reimer P; Diehm N; Baeriswyl JL; Brechtel K; Speck U; Zeller T
J Endovasc Ther; 2020 Apr; 27(2):276-286. PubMed ID: 32096451
[No Abstract] [Full Text] [Related]
8. Intraluminal vs Subintimal Drug-Coated Balloon Angioplasty for the Treatment of Femoropopliteal Chronic Total Occlusions.
Toyoshima T; Takahara M; Iida O; Tomoi Y; Kawasaki D; Tanaka A; Yamauchi Y; Tobita K; Kozuki A; Fujihara M; Higuchi Y; Soga Y;
JACC Cardiovasc Interv; 2024 Mar; 17(5):608-618. PubMed ID: 38479962
[TBL] [Abstract][Full Text] [Related]
9. [Efficacy and safety of drug-coated balloon angioplasty in treatment of lower extremity arterial occlusive disease: a meta-analysis of 11 trials].
Ran K; Wang C; Zhao Y; Xiang Z
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Nov; 36(11):1566-1572. PubMed ID: 27881352
[TBL] [Abstract][Full Text] [Related]
10. Laser atherectomy and drug-coated balloons for the treatment of femoropopliteal in-stent restenosis: 2-Year outcomes.
Kokkinidis DG; Behan S; Jawaid O; Hossain P; Giannopoulos S; Singh GD; Laird JR; Valle JA; Waldo SW; Armstrong EJ
Catheter Cardiovasc Interv; 2020 Feb; 95(3):439-446. PubMed ID: 31816169
[TBL] [Abstract][Full Text] [Related]
11. Midterm Outcome of Directional Atherectomy Combined with Drug-Coated Balloon Angioplasty Versus Drug-Coated Balloon Angioplasty Alone for Femoropopliteal Arteriosclerosis Obliterans.
Cai Z; Guo L; Qi L; Cui S; Tong Z; Guo J; Wang Z; Gu Y
Ann Vasc Surg; 2020 Apr; 64():181-187. PubMed ID: 31449956
[TBL] [Abstract][Full Text] [Related]
12. Combination of Rotarex Thrombectomy and Drug-Coated Balloon for the Treatment of Femoropopliteal Artery In-Stent Restenosis.
Liao CJ; Song SH; Li T; Zhang Y; Zhang WD
Ann Vasc Surg; 2019 Oct; 60():301-307. PubMed ID: 31075447
[TBL] [Abstract][Full Text] [Related]
13. Drug-coated balloon angioplasty for in-stent restenosis of femoropopliteal arteries: a meta-analysis.
Cassese S; Ndrepepa G; Kufner S; Byrne RA; Giacoppo D; Ott I; Laugwitz KL; Schunkert H; Kastrati A; Fusaro M
EuroIntervention; 2017 Jul; 13(4):483-489. PubMed ID: 28169215
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Rotational Atherectomy Followed by Drug-coated Balloon Angioplasty for the Treatment of Femoropopliteal Lesions-Comparison with Sole Drug-coated Balloon Revascularization: Two-year Outcomes.
Rodoplu O; Oztas DM; Meric M; Beyaz MO; Ulukan MO; Yildiz CE; Unal O; Ugurlucan M
Ann Vasc Surg; 2021 May; 73():222-233. PubMed ID: 33359329
[TBL] [Abstract][Full Text] [Related]
15. Excimer laser atherectomy combined with drug-coated balloon angioplasty for the treatment of femoropopliteal arteriosclerosis obliterans.
Su Z; Li Y; Yang S; Guo J; Guo L; Gu Y
Ann R Coll Surg Engl; 2022 Nov; 104(9):667-672. PubMed ID: 35446161
[TBL] [Abstract][Full Text] [Related]
16. The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty.
Scheinert D; Duda S; Zeller T; Krankenberg H; Ricke J; Bosiers M; Tepe G; Naisbitt S; Rosenfield K
JACC Cardiovasc Interv; 2014 Jan; 7(1):10-9. PubMed ID: 24456716
[TBL] [Abstract][Full Text] [Related]
17. Drug-coated balloon angioplasty: predicting outcomes based on different patterns of drug-eluting stent restenosis.
Wang X; Lu W; Wang X; Pan L; Fu W; Liu Q; Han Z; Sun G; Qin X; Li R; Zheng X; Shan Y; Qiu C
Int J Cardiovasc Imaging; 2020 Feb; 36(2):171-178. PubMed ID: 31919705
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Drug-Coated Balloon Angioplasty Alone and Directional Atherectomy Combined with Drug-Coated Balloon Angioplasty in Patients with Lower Extremity Peripheral Arterial Disease with Claudication.
Kavala AA; Kuserli Y; Turkyilmaz G; Yesiltas MA; Turkyilmaz S
Ann Vasc Surg; 2023 Mar; 90():162-171. PubMed ID: 36404474
[TBL] [Abstract][Full Text] [Related]
19. Network meta-analysis of drug-coated balloon angioplasty versus primary nitinol stenting for femoropopliteal atherosclerotic disease.
Abdoli S; Mert M; Lee WM; Ochoa CJ; Katz SG
J Vasc Surg; 2021 May; 73(5):1802-1810.e4. PubMed ID: 33249205
[TBL] [Abstract][Full Text] [Related]
20. Drug-coated Balloon Angioplasty of Femoropopliteal Lesions Maintained Superior Efficacy over Conventional Balloon: 2-year Results of the Randomized EffPac Trial.
Teichgräber U; Lehmann T; Aschenbach R; Scheinert D; Zeller T; Brechtel K; Blessing E; Lichtenberg M; von Flotow P; Heilmeier B; Sixt S; Brucks S; Erbel C; Beschorner U; Werk M; Riambau V; Wienke A; Klumb CT; Thieme M
Radiology; 2020 May; 295(2):478-487. PubMed ID: 32125256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
